As a result of the mild winter and increased demand during the coronavirus pandemic, demand for clinical thermometers is currently below average. For this reason and in order to reduce inventories, we are planning short-time working at the Geratal plant from April 1, 2024 to October 31, 2024. We expect sales of clinical thermometers to normalize by the end of the year.

The update published by Alster Research on March 19, 2024 continues to issue a buy recommendation for the Geratherm share, with a new price target of EUR 9.15.

Research Hub gives investors free access to updates of Geratherm Medical's digital coverage.

Alternatively, you can find the update as a PDF file here.